Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastasesPaola Queirolo, Vanna Chiarion‐Sileni, Francesco Spagnolo et al.|Journal of Neuro-Oncology|2014Cited by 119
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective StudyElena Bolzacchini, Francesco Dentali, Chiara Rossini et al.|Clinical Genitourinary Cancer|2019Cited by 7
Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinibElena Bolzacchini, Francesco Dentali, Monica Giordano et al.|Tumori Journal|2021Cited by 6
Efficacy and safety data from elderly patients with pretreated advanced melanoma in the Italian cohort of ipilimumab expanded access programme (EAP).Vanna Chiarion‐Sileni, Paola Queirolo, Jacopo Pigozzo et al.|Journal of Clinical Oncology|2013Cited by 5
Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patientsMaria Lucia Iacovino, Francesco Perrone, Laura Arenare et al.|Lung Cancer|2026Cited by 0